Morgan Stanley 10x Genomics, Inc. Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Morgan Stanley holds 6,476,307 shares of TXG stock, worth $90.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

6,476,307

Previous 5,773,868 12.17%

Holding current value

$90.9 Million

Previous $112 Million 30.22%

% of portfolio

0.01%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$15.71 - $23.49 $11 Million - $16.5 Million	702,439 Added 12.17%	6,476,307 $146 Million
Q2 2024 Oct 17, 2024	BUY	$19.45 - $37.37 $11.9 Million - $22.8 Million	609,361 Added 11.8%	5,773,868 $112 Million
Q2 2024 Aug 14, 2024	BUY	$19.45 - $37.37 $11.9 Million - $22.8 Million	609,361 Added 11.8%	5,773,868 $112 Million
Q1 2024 Oct 17, 2024	SELL	$36.08 - $54.3 $22 Million - $33.1 Million	-609,361 Reduced 10.55%	5,164,507 $194 Million
Q1 2024 Aug 16, 2024	BUY	$36.08 - $54.3 $35.5 Million - $53.5 Million	985,092 Added 23.57%	5,164,507 $194 Million
Q1 2024 May 15, 2024	BUY	$36.08 - $54.3 $35.5 Million - $53.5 Million	985,092 Added 23.57%	5,164,507 $194 Million
Q4 2023 Aug 16, 2024	SELL	$34.32 - $57.55 $54.7 Million - $91.8 Million	-1,594,453 Reduced 27.61%	4,179,415 $234 Million
Q4 2023 Feb 13, 2024	SELL	$34.32 - $57.55 $5.86 Million - $9.82 Million	-170,635 Reduced 3.92%	4,179,415 $234 Million
Q3 2023 Nov 15, 2023	SELL	$40.86 - $62.98 $53 Million - $81.8 Million	-1,298,035 Reduced 22.98%	4,350,050 $179 Million
Q2 2023 Aug 14, 2023	SELL	$50.96 - $58.72 $248 Million - $286 Million	-4,872,606 Reduced 46.31%	5,648,085 $315 Million
Q1 2023 May 15, 2023	BUY	$35.33 - $55.79 $7.1 Million - $11.2 Million	200,995 Added 1.95%	10,520,691 $587 Million
Q4 2022 Feb 14, 2023	SELL	$24.4 - $41.3 $2.63 Million - $4.45 Million	-107,676 Reduced 1.03%	10,319,696 $376 Million
Q3 2022 Nov 14, 2022	BUY	$28.48 - $52.59 $43.6 Million - $80.5 Million	1,530,496 Added 17.2%	10,427,372 $297 Million
Q2 2022 Oct 27, 2022	SELL	$36.95 - $82.41 $15 Million - $33.4 Million	-404,980 Reduced 4.35%	8,896,876 $403 Million
Q2 2022 Aug 15, 2022	SELL	$36.95 - $82.41 $15 Million - $33.4 Million	-404,980 Reduced 4.35%	8,896,876 $403 Million
Q1 2022 Oct 27, 2022	BUY	$55.7 - $145.79 $22.6 Million - $59 Million	404,980 Added 4.55%	9,301,856 $708 Million
Q1 2022 May 13, 2022	BUY	$55.7 - $145.79 $247 Million - $648 Million	4,443,059 Added 91.44%	9,301,856 $708 Million
Q4 2021 Feb 14, 2022	SELL	$135.05 - $182.59 $164 Million - $222 Million	-1,216,315 Reduced 20.02%	4,858,797 $724 Million
Q3 2021 Nov 15, 2021	BUY	$145.58 - $192.14 $884 Million - $1.17 Billion	6,075,112 New	6,075,112 $884 Million

Others Institutions Holding TXG

# of Institutions

291

Shares Held

94.7M

Call Options Held

263K

Put Options Held

85.1K

View Full List

About 10x Genomics, Inc.

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $1.33B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

More about TXG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account